{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:59:57Z","timestamp":1764305997258,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK120292","DK122734","HL158691","AG062104"],"award-info":[{"award-number":["DK120292","DK122734","HL158691","AG062104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12015-022-10473-2","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T19:05:59Z","timestamp":1667847959000},"page":"700-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autologous Extracellular Vesicles Attenuate Cardiac Injury in Experimental Atherosclerotic Renovascular Disease More Effectively Than Their Parent Mesenchymal Stem\/Stromal Cells"],"prefix":"10.1007","volume":"19","author":[{"given":"Siting","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyra L.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishran M.","family":"Saadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Eirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-3887","authenticated-orcid":false,"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"3","key":"10473_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1067\/mva.2002.127351","volume":"36","author":"KJ Hansen","year":"2002","unstructured":"Hansen, K. J., Edwards, M. S., Craven, T. E., et al. (2002). Prevalence of renovascular disease in the elderly: a population-based study. Journal of Vascular Surgery, 36(3), 443\u2013451.","journal-title":"Journal of Vascular Surgery"},{"issue":"9","key":"10473_CR2","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1681\/ASN.2014121274","volume":"26","author":"SC Textor","year":"2015","unstructured":"Textor, S. C., & Lerman, L. O. (2015). Paradigm shifts in atherosclerotic renovascular disease: Where are we now? Journal of the American Society of Nephrology, 26(9), 2074\u20132080.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10473_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.158.7.761","volume":"158","author":"RE Zierler","year":"1998","unstructured":"Zierler, R. E., Bergelin, R. O., Polissar, N. L., et al. (1998). Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Archives of Internal Medicine, 158(7), 761\u2013767.","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10473_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall, J. E., Mouton, A. J., da Silva, A. A., et al. (2021). Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovascular Research, 117(8), 1859\u20131876.","journal-title":"Cardiovascular Research"},{"key":"10473_CR5","doi-asserted-by":"publisher","first-page":"630412","DOI":"10.3389\/fcell.2021.630412","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang, J., Sun, X., Wang, X., et al. (2021). Grb2 induces cardiorenal syndrome type 3: Roles of IL-6, cardiomyocyte bioenergetics, and Akt\/mTOR pathway. Frontiers in Cell and Developmental Biology, 9, 630412.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"10473_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biomaterials.2005.05.071","volume":"27","author":"H Betre","year":"2006","unstructured":"Betre, H., Ong, S. R., Guilak, F., et al. (2006). Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials, 27(1), 91\u201399.","journal-title":"Biomaterials"},{"issue":"3\u20134","key":"10473_CR7","first-page":"335","volume":"41","author":"P Angele","year":"2004","unstructured":"Angele, P., Schumann, D., Angele, M., et al. (2004). Cyclic, mechanical compression enhances chondrogenesis of mesenchymal progenitor cells in tissue engineering scaffolds. Biorheology, 41(3\u20134), 335\u2013346.","journal-title":"Biorheology"},{"key":"10473_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass, R., Kasper, C., B\u00f6hm, S., et al. (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling: CCS, 9, 12.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10473_CR9","doi-asserted-by":"crossref","unstructured":"Elahi, K. C., Klein, G., Avci-Adali, M., et al. (2016). Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns.\u00a0Stem Cells International, 2016, 5646384.","DOI":"10.1155\/2016\/5646384"},{"issue":"2\u20133","key":"10473_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000046182","volume":"170","author":"JE Dennis","year":"2002","unstructured":"Dennis, J. E., Carbillet, J. P., Caplan, A. I., et al. (2002). The STRO-1 + marrow cell population is multipotential. Cells, Tissues, Organs, 170(2\u20133), 73\u201382.","journal-title":"Cells, Tissues, Organs"},{"issue":"10","key":"10473_CR11","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3727\/096368914X685582","volume":"24","author":"A Eirin","year":"2015","unstructured":"Eirin, A., Zhu, X. Y., Ebrahimi, B., et al. (2015). Intrarenal delivery of mesenchymal stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension. Cell Transplantation, 24(10), 2041\u20132053.","journal-title":"Cell Transplantation"},{"key":"10473_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer, E., Benseler, V., Kroemer, A., et al. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in Immunology, 3, 297.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10473_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/ten.teb.2018.0118","volume":"25","author":"D Kouroupis","year":"2019","unstructured":"Kouroupis, D., Sanjurjo-Rodriguez, C., Jones, E., et al. (2019). Mesenchymal stem cell functionalization for enhanced therapeutic applications. Tissue Engineering. Part B, Reviews, 25(1), 55\u201377.","journal-title":"Tissue Engineering. Part B, Reviews"},{"issue":"4","key":"10473_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00109-013-1110-5","volume":"92","author":"S Bian","year":"2014","unstructured":"Bian, S., Zhang, L., Duan, L., et al. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. Journal of Molecular Medicine (Berlin, Germany), 92(4), 387\u2013397.","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10473_CR15","doi-asserted-by":"crossref","unstructured":"Kami\u0144ska, A., Platt, M., Kasprzyk, J., et al. (2016). Urinary extracellular vesicles: Potential biomarkers of renal function in diabetic patients.\u00a0Journal of Diabetes Research, 2016, 5741518.","DOI":"10.1155\/2016\/5741518"},{"issue":"1","key":"10473_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/acsnano.6b07607","volume":"11","author":"JP Armstrong","year":"2017","unstructured":"Armstrong, J. P., Holme, M. N., & Stevens, M. M. (2017). Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano, 11(1), 69\u201383.","journal-title":"ACS Nano"},{"issue":"4","key":"10473_CR17","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1021\/acsnano.5b08015","volume":"10","author":"S Fais","year":"2016","unstructured":"Fais, S., O\u2019Driscoll, L., Borras, F. E., et al. (2016). Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano, 10(4), 3886\u20133899.","journal-title":"ACS Nano"},{"issue":"18","key":"10473_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/scd.2020.0030","volume":"29","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Zhu, X., Zhang, L., et al. (2020). Mesenchymal stem\/stromal cells and their extracellular vesicle progeny decrease injury in poststenotic swine kidney through different mechanisms. Stem Cells and Development, 29(18), 1190\u20131200.","journal-title":"Stem Cells and Development"},{"issue":"1","key":"10473_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.kint.2016.12.023","volume":"92","author":"A Eirin","year":"2017","unstructured":"Eirin, A., Zhu, X. Y., Puranik, A. S., et al. (2017). Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. Kidney International, 92(1), 114\u2013124.","journal-title":"Kidney International"},{"key":"10473_CR20","doi-asserted-by":"crossref","unstructured":"Eirin, A., Zhu, X. Y., Puranik, A. S., et al. (2017). Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells. PLoS One, 12(3), e0174303.","DOI":"10.1371\/journal.pone.0174303"},{"issue":"5","key":"10473_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/sctm.18-0171","volume":"8","author":"A Eirin","year":"2019","unstructured":"Eirin, A., Zhu, X. Y., Woollard, J. R., et al. (2019). Metabolic syndrome interferes with packaging of proteins within porcine mesenchymal stem cell-derived extracellular vesicles. Stem Cells Translational Medicine, 8(5), 430\u2013440.","journal-title":"Stem Cells Translational Medicine"},{"key":"10473_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13098-018-0359-9","volume":"10","author":"Y Meng","year":"2018","unstructured":"Meng, Y., Eirin, A., Zhu, X. Y., et al. (2018). The metabolic syndrome modifies the mRNA expression profile of extracellular vesicles derived from porcine mesenchymal stem cells. Diabetology & Metabolic Syndrome, 10, 58.","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"12","key":"10473_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/0929866525666171123213148","volume":"24","author":"M Ijaz","year":"2018","unstructured":"Ijaz, M., Wang, F., Shahbaz, M., et al. (2018). The role of Grb2 in cancer and peptides as Grb2 antagonists. Protein and Peptide Letters, 24(12), 1084\u20131095.","journal-title":"Protein and Peptide Letters"},{"issue":"2","key":"10473_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-017-0211-4","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen, D., Si, W., Shen, J., et al. (2018). miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB\/GRB2 in breast cancer cells. Cell Death and Disease, 9(2), 188.","journal-title":"Cell Death and Disease"},{"issue":"9","key":"10473_CR25","first-page":"5500","volume":"13","author":"KL Suen","year":"1993","unstructured":"Suen, K. L., Bustelo, X. R., Pawson, T., et al. (1993). Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors. Molecular and Cellular Biology, 13(9), 5500\u20135512.","journal-title":"Molecular and Cellular Biology"},{"issue":"5116","key":"10473_CR26","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1126\/science.8391166","volume":"260","author":"K Baltensperger","year":"1993","unstructured":"Baltensperger, K., Kozma, L. M., Cherniack, A. D., et al. (1993). Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science, 260(5116), 1950\u20131952.","journal-title":"Science"},{"issue":"21","key":"10473_CR27","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.112.000882","volume":"127","author":"J Ganesan","year":"2013","unstructured":"Ganesan, J., Ramanujam, D., Sassi, Y., et al. (2013). MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation, 127(21), 2097\u20132106.","journal-title":"Circulation"},{"issue":"4","key":"10473_CR28","doi-asserted-by":"publisher","first-page":"18958","DOI":"10.4238\/2015.December.29.2","volume":"14","author":"Y Xia","year":"2015","unstructured":"Xia, Y., Sheng, J., Liang, G. Y., et al. (2015). miR-96 inhibits cardiac hypertrophy by targeting growth factor receptor-bound 2. Genetics and Molecular Research, 14(4), 18958\u201318964.","journal-title":"Genetics and Molecular Research"},{"key":"10473_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2019.06.011","volume":"133","author":"F Sun","year":"2019","unstructured":"Sun, F., Zhuang, Y., Zhu, H., et al. (2019). LncRNA PCFL promotes cardiac fibrosis via miR-378\/GRB2 pathway following myocardial infarction. Journal of Molecular and Cellular Cardiology, 133, 188\u2013198.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10473_CR30","doi-asserted-by":"publisher","first-page":"104718","DOI":"10.1016\/j.phrs.2020.104718","volume":"155","author":"XR Zhao","year":"2020","unstructured":"Zhao, X. R., Zhang, Z., Gao, M., et al. (2020). MicroRNA-27a-3p aggravates renal ischemia\/reperfusion injury by promoting oxidative stress via targeting growth factor receptor-bound protein 2. Pharmacological Research, 155, 104718.","journal-title":"Pharmacological Research"},{"issue":"6","key":"10473_CR31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.bbadis.2019.01.020","volume":"1865","author":"D Chen","year":"2019","unstructured":"Chen, D., Li, Z., Bao, P., et al. (2019). Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1865(6), 1253\u20131264.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"2","key":"10473_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/oby.20971","volume":"23","author":"AS Pawar","year":"2015","unstructured":"Pawar, A. S., Zhu, X. Y., Eirin, A., et al. (2015). Adipose tissue remodeling in a novel domestic porcine model of diet-induced obesity. Obesity (Silver Spring), 23(2), 399\u2013407.","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10473_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1681\/ASN.V1071455","volume":"10","author":"LO Lerman","year":"1999","unstructured":"Lerman, L. O., Schwartz, R. S., Grande, J. P., et al. (1999). Noninvasive evaluation of a novel swine model of renal artery stenosis. Journal of the American Society of Nephrology, 10(7), 1455\u20131465.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10473_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/HYPERTENSIONAHA.115.05478","volume":"66","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Li, Z. L., Eirin, A., et al. (2015). Cardiac metabolic alterations in hypertensive obese pigs. Hypertension, 66(2), 430\u2013436.","journal-title":"Hypertension"},{"issue":"4","key":"10473_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1681\/ASN.2006090976","volume":"18","author":"XY Zhu","year":"2007","unstructured":"Zhu, X. Y., Daghini, E., Chade, A. R., et al. (2007). Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. Journal of the American Society of Nephrology, 18(4), 1209\u20131217.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10473_CR36","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/ATVBAHA.109.190546","volume":"29","author":"J Lin","year":"2009","unstructured":"Lin, J., Zhu, X., Chade, A. R., et al. (2009). Monocyte chemoattractant proteins mediate myocardial microvascular dysfunction in swine renovascular hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(11), 1810\u20131816.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10473_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/stem.1263","volume":"31","author":"XY Zhu","year":"2013","unstructured":"Zhu, X. Y., Urbieta-Caceres, V., Krier, J. D., et al. (2013). Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells, 31(1), 117\u2013125.","journal-title":"Stem Cells"},{"issue":"6","key":"10473_CR38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1681\/ASN.2014030248","volume":"26","author":"XY Zhu","year":"2015","unstructured":"Zhu, X. Y., Ebrahimi, B., Eirin, A., et al. (2015). Renal vein levels of microRNA-26a are lower in the poststenotic kidney. Journal of the American Society of Nephrology, 26(6), 1378\u20131388.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10473_CR39","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1177\/0963689718780942","volume":"27","author":"A Eirin","year":"2018","unstructured":"Eirin, A., Zhu, X. Y., Jonnada, S., et al. (2018). Mesenchymal stem cell-derived extracellular vesicles improve the renal microvasculature in metabolic renovascular disease in swine. Cell Transplantation, 27(7), 1080\u20131095.","journal-title":"Cell Transplantation"},{"issue":"3","key":"10473_CR40","first-page":"H669","volume":"314","author":"F Yuan","year":"2018","unstructured":"Yuan, F., Hedayat, A. F., Ferguson, C. M., et al. (2018). Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome. American Journal of Physiology Heart and Circulatory Physiology, 314(3), H669-h680.","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"2","key":"10473_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ndt\/gft305","volume":"29","author":"A Eirin","year":"2014","unstructured":"Eirin, A., Zhang, X., Zhu, X. Y., et al. (2014). Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrology, Dialysis, Transplantation, 29(2), 274\u2013282.","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"1","key":"10473_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/scrt541","volume":"6","author":"A Eirin","year":"2015","unstructured":"Eirin, A., Zhu, X. Y., Ferguson, C. M., et al. (2015). Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease. Stem Cell Research & Therapy, 6(1), 7.","journal-title":"Stem Cell Research & Therapy"},{"key":"10473_CR43","doi-asserted-by":"publisher","first-page":"36120","DOI":"10.1038\/srep36120","volume":"6","author":"A Eirin","year":"2016","unstructured":"Eirin, A., Zhu, X. Y., Puranik, A. S., et al. (2016). Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem\/stromal cells. Scientific Reports, 6, 36120.","journal-title":"Scientific Reports"},{"issue":"4","key":"10473_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0094-0143(01)80034-3","volume":"28","author":"L Lerman","year":"2001","unstructured":"Lerman, L., & Textor, S. C. (2001). Pathophysiology of ischemic nephropathy. Urologic Clinics of North America, 28(4), 793\u2013803. ix.","journal-title":"Urologic Clinics of North America"},{"issue":"7","key":"10473_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0003319715609013","volume":"67","author":"EL Wallace","year":"2016","unstructured":"Wallace, E. L., Tasan, E., Cook, B. S., et al. (2016). Long-term outcomes and causes of death in patients with renovascular disease undergoing renal artery stenting. Angiology, 67(7), 657\u2013663.","journal-title":"Angiology"},{"issue":"3","key":"10473_CR46","doi-asserted-by":"publisher","first-page":"617","DOI":"10.33594\/000000044","volume":"52","author":"SR Kim","year":"2019","unstructured":"Kim, S. R., Eirin, A., Zhang, X., et al. (2019). Mitochondrial protection partly mitigates kidney cellular senescence in swine atherosclerotic renal artery stenosis. Cellular Physiology and Biochemistry, 52(3), 617\u2013632.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"2","key":"10473_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-019-0772-8","volume":"115","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Zhu, X. Y., Zhao, Y., et al. (2020). Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease. Basic Research in Cardiology, 115(2), 16.","journal-title":"Basic Research in Cardiology"},{"issue":"12","key":"10473_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","volume":"150","author":"L Bax","year":"2009","unstructured":"Bax, L., Woittiez, A. J., Kouwenberg, H. J., et al. (2009). Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine, 150(12), 840\u2013848.","journal-title":"Annals of Internal Medicine"},{"issue":"20","key":"10473_CR49","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"K Wheatley","year":"2009","unstructured":"Wheatley, K., Ives, N., Gray, R., et al. (2009). Revascularization versus medical therapy for renal-artery stenosis. New England Journal of Medicine, 361(20), 1953\u20131962.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10473_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/jmcc.2001.1505","volume":"34","author":"Y Higuchi","year":"2002","unstructured":"Higuchi, Y., Otsu, K., Nishida, K., et al. (2002). Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 34(2), 233\u2013240.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"12","key":"10473_CR51","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","volume":"118","author":"L Zhao","year":"2016","unstructured":"Zhao, L., Cheng, G., Jin, R., et al. (2016). Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction. Circulation Research, 118(12), 1918\u20131929.","journal-title":"Circulation Research"},{"issue":"1","key":"10473_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semnephrol.2018.10.003","volume":"39","author":"L Di Lullo","year":"2019","unstructured":"Di Lullo, L., Reeves, P. B., Bellasi, A., et al. (2019). Cardiorenal syndrome in acute kidney injury. Seminars in Nephrology, 39(1), 31\u201340.","journal-title":"Seminars in Nephrology"},{"issue":"3","key":"10473_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10741-020-10034-0","volume":"26","author":"N Ghionzoli","year":"2021","unstructured":"Ghionzoli, N., Sciaccaluga, C., Mandoli, G. E., et al. (2021). Cardiogenic shock and acute kidney injury: the rule rather than the exception. Heart Failure Reviews, 26(3), 487\u2013496.","journal-title":"Heart Failure Reviews"},{"issue":"6","key":"10473_CR54","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/01.ASN.0000064946.94590.46","volume":"14","author":"KJ Kelly","year":"2003","unstructured":"Kelly, K. J. (2003). Distant effects of experimental renal ischemia\/reperfusion injury. Journal of the American Society of Nephrology, 14(6), 1549\u20131558.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10473_CR55","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1161\/01.CIR.94.9.2193","volume":"94","author":"BC Gho","year":"1996","unstructured":"Gho, B. C., Schoemaker, R. G., van den Doel, M. A., et al. (1996). Myocardial protection by brief ischemia in noncardiac tissue. Circulation, 94(9), 2193\u20132200.","journal-title":"Circulation"},{"issue":"4","key":"10473_CR56","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105(4), 1815\u20131822.","journal-title":"Blood"},{"issue":"1","key":"10473_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.V89.1.261","volume":"89","author":"LC Berger","year":"1997","unstructured":"Berger, L. C., & Hawley, R. G. (1997). Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells. Blood, 89(1), 261\u2013271.","journal-title":"Blood"},{"key":"10473_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jmgm.2017.12.008","volume":"80","author":"P Mohanty","year":"2018","unstructured":"Mohanty, P., & Bhatnagar, S. (2018). Structure of focal adhesion kinase in healthy heart versus pathological cardiac hypertrophy: A modeling and simulation study. Journal of Molecular Graphics and Modelling, 80, 15\u201324.","journal-title":"Journal of Molecular Graphics and Modelling"},{"key":"10473_CR59","doi-asserted-by":"crossref","unstructured":"Chang, P. M., Li, K. L., & Lin, Y. C. (2019). Fucoidan Fucoxanthin ameliorated cardiac function via IRS1\/GRB2\/ SOS1, GSK3\u03b2\/CREB pathways and metabolic pathways in senescent mice. Marine Drugs, 17(1).","DOI":"10.3390\/md17010069"},{"key":"10473_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1476-4598-13-95","volume":"13","author":"Y Qu","year":"2014","unstructured":"Qu, Y., Chen, Q., Lai, X., et al. (2014). SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1. Molecular Cancer, 13, 95.","journal-title":"Molecular Cancer"},{"key":"10473_CR61","doi-asserted-by":"publisher","first-page":"705676","DOI":"10.3389\/fcell.2021.705676","volume":"9","author":"J Johnson","year":"2021","unstructured":"Johnson, J., Shojaee, M., Mitchell, J., Crow, et al. (2021). From mesenchymal stromal cells to engineered extracellular vesicles: A new therapeutic paradigm. Frontiers in Cell and Developmental Biology, 9, 705676.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10473_CR62","doi-asserted-by":"crossref","unstructured":"Yun, C. W., & Lee, S. H. (2019). Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease.\u00a0International Journal of Molecular Sciences, 20(4).","DOI":"10.3390\/ijms20040982"},{"key":"10473_CR63","doi-asserted-by":"crossref","unstructured":"Wang, X., Chen, Y., Zhao, Z., et al. (2018). Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction.\u00a0Journal of the American Heart Association, 7(15), e008737.","DOI":"10.1161\/JAHA.118.008737"},{"issue":"6","key":"10473_CR64","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1159\/000438594","volume":"37","author":"X Teng","year":"2015","unstructured":"Teng, X., Chen, L., Chen, W., et al. (2015). Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cellular Physiology and Biochemistry, 37(6), 2415\u20132424.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"10473_CR65","doi-asserted-by":"publisher","first-page":"1324730","DOI":"10.1080\/20013078.2017.1324730","volume":"6","author":"X Zhu","year":"2017","unstructured":"Zhu, X., Badawi, M., Pomeroy, S., et al. (2017). Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. Journal of Extracellular Vesicles, 6(1), 1324730.","journal-title":"Journal of Extracellular Vesicles"},{"issue":"1","key":"10473_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/cyto.a.23165","volume":"93","author":"Y Meng","year":"2018","unstructured":"Meng, Y., Eirin, A., Zhu, X. Y., et al. (2018). The metabolic syndrome alters the miRNA signature of porcine adipose tissue-derived mesenchymal stem cells. Cytometry. Part A, 93(1), 93\u2013103.","journal-title":"Cytometry. Part A"},{"key":"10473_CR67","doi-asserted-by":"publisher","first-page":"155080","DOI":"10.1016\/j.cyto.2020.155080","volume":"130","author":"AS Pawar","year":"2020","unstructured":"Pawar, A. S., Eirin, A., Tang, H., et al. (2020). Upregulated tumor necrosis factor-\u03b1 transcriptome and proteome in adipose tissue-derived mesenchymal stem cells from pigs with metabolic syndrome. Cytokine, 130, 155080.","journal-title":"Cytokine"},{"issue":"2","key":"10473_CR68","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3892\/ol.2016.5521","volume":"13","author":"NN Mon","year":"2017","unstructured":"Mon, N. N., Senga, T., & Ito, S. (2017). Interleukin-1\u03b2 activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells. Oncology Letters, 13(2), 955\u2013960.","journal-title":"Oncology Letters"},{"issue":"11","key":"10473_CR69","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1084\/jem.189.11.1707","volume":"189","author":"E Hildt","year":"1999","unstructured":"Hildt, E., & Oess, S. (1999). Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. Journal of Experimental Medicine, 189(11), 1707\u20131714.","journal-title":"Journal of Experimental Medicine"},{"key":"10473_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/bs.mie.2020.09.002","volume":"645","author":"M Dehghani","year":"2020","unstructured":"Dehghani, M., & Gaborski, T. R. (2020). Fluorescent labeling of extracellular vesicles. Methods in Enzymology, 645, 15\u201342.","journal-title":"Methods in Enzymology"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10473-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-022-10473-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10473-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:05:19Z","timestamp":1680519919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-022-10473-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10473"],"URL":"https:\/\/doi.org\/10.1007\/s12015-022-10473-2","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"type":"print","value":"2629-3269"},{"type":"electronic","value":"2629-3277"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"20 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mayo Clinical Animal Care and Use Committee (A65014-15).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"LOL is an advisor to AstraZeneca, Butterfly Biosciences, CureSpec, Beren Therapeutics, and Ribocure Pharmaceuticals. The other authors indicated no potential conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}